Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 20222023

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to __________

Commission file number 000-53851

Mobivity Holdings Corp.

(Exact Name of Registrant as Specified in Its Charter)

Nevada

26-3439095

Nevada

26-3439095

(State or Other Jurisdiction of

(I.R.S. Employer

Incorporation or Organization)

Identification No.)

3133 West Frye Road, # 215

Chandler, Arizona 85226

(Address of Principal Executive Offices & Zip Code)Offices)

(877) 282-7660

(Registrant’s Telephone Number)Number, including Area Code)

N/A

(Former name, former address, and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

None

None

None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Large acceleratedNon-accelerated filer

¨

Accelerated filerSmaller reporting company

¨

Non-accelerated filerEmerging Company

x

Smaller reporting company

x

Emerging Company

¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of May 13, 2022,11, 2023, the registrant had 58,598,88565,797,567 shares of common stock, par value $0.001 of the registrantper share, issued and outstanding. 



MOBIVITY HOLDINGS CORP.

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION

1

Item 1. Financial Statements

1

Condensed Consolidated Balance Sheets

1

Condensed Consolidated Statements of Operations and Comprehensive Loss

2

Condensed Consolidated Statement of Stockholders’ Equity (Deficit)

3

Condensed Consolidated Statements of Cash Flows

54

Notes to Condensed Consolidated Financial Statements

65

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

1915

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

2418

Item 4. Controls and Procedures.

2518

PART II – OTHER INFORMATION

19

26Item 1. Legal Proceedings19
Item 1A. Risk Factors19
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds19
Item 3. Defaults Upon Senior Securities19
Item 4. Mine Safety Disclosures19
Item 5. Other Information19

Item 6. Exhibits

19

Item 6. ExhibitsSIGNATURES

2620

SIGNATURES

27


PART I FINANCIAL INFORMATION

Item 1. Financial Statements

Mobivity Holdings Corp.

Condensed Consolidated Balance Sheets

  

March 31,

  

December 31,

 
  

2023

  

2022

 
         

ASSETS

        

Current assets

        

Cash

 $2,581,597  $426,740 

Accounts receivable, net of allowance for doubtful accounts $10,820 and $34,446, respectively

  749,986   1,081,183 

Other current assets

  212,939   195,017 

Total current assets

  3,544,522   1,702,940 

Right to use lease assets

  930,658   981,896 

Intangible assets, net

  143,857   194,772 

Other assets

  142,464   137,917 

TOTAL ASSETS

 $4,761,501  $3,017,525 

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

        

Current liabilities

        

Accounts payable

 $3,335,917  $3,412,612 

Accrued interest

  442,269   443,448 

Accrued and deferred personnel compensation

  495,209   569,347 

Deferred revenue and customer deposits

  704,740   902,727 

Related party notes payable, net - current maturities

  1,327,265   2,711,171 

Notes payable, net - current maturities

  24,354   32,617 

Operating lease liability, noncurrent

  257,614   251,665 

Other current liabilities

  15,462   49,541 

Total current liabilities

  6,602,830   8,373,128 
         

Non-current liabilities

        

Related party notes payable, net - long term

  3,896,763   2,481,290 

Notes payable, net - long term

  29,565   31,092 

Operating lease liability

  870,057   936,924 

Total non-current liabilities

  4,796,385   3,449,306 

Total liabilities

  11,399,215   11,822,434 
         

Stockholders' equity (deficit)

        

Common stock, $0.001 par value; 100,000,000 shares authorized; 65,607,411 and 61,311,155, shares issued and outstanding

  65,607   61,311 

Equity payable

  317,086   324,799 

Additional paid-in capital

  113,423,638   108,806,353 

Accumulated other comprehensive income (loss)

  (69,461)  (100,963)

Accumulated deficit

  (120,374,584)  (117,896,409)

Total stockholders' equity (deficit)

  (6,637,714)  (8,804,909)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

 $4,761,501  $3,017,525 

See accompanying notes to consolidated financial statements.

1

March 31,

December 31,

2022

2021

(Unaudited)

(Audited)

ASSETS

Current assets

Cash

$

1,455,147

$

735,424

Accounts receivable, net of allowance for doubtful accounts of $53,514 and $56,340, respectively

491,004

578,303

Other current assets

333,207

227,458

Total current assets

2,279,358

1,541,185

Goodwill

411,183

411,183

Right to use lease assets

1,132,317

1,187,537

Intangible assets, net

1,015,690

1,124,720

Other assets

157,366

173,325

TOTAL ASSETS

$

4,995,914

$

4,437,950

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current liabilities

Accounts payable

$

3,503,464

$

3,823,909

Accrued interest

305,364

172,239

Accrued and deferred personnel compensation

292,430

495,533

Deferred revenue and customer deposits

173,379

377,170

Related party notes payable

1,479,167

819,531

Notes payable, net - current maturities

41,577

69,052

Operating lease liability

237,761

229,240

Other current liabilities

9,071

Total current liabilities

6,033,142

5,995,745

Non-current liabilities

Related party notes payable, net - long term

1,857,079

2,498,711

Notes payable, net - long term

61,794

39,086

Operating lease liability

1,127,670

1,188,589

Total non-current liabilities

3,046,543

3,726,386

Total liabilities

9,079,685

9,722,131

Stockholders' equity (deficit)

Common stock, $0.001 par value; 100,000,000 shares authorized; 58,598,885 and 55,410,695, shares issued and outstanding

58,599

55,411

Equity payable

100,862

100,862

Additional paid-in capital

105,590,137

102,446,921

Accumulated other comprehensive income (loss)

(64,983)

(52,088)

1


Accumulated deficit

(109,768,386)

(107,835,287)

Total stockholders' equity (deficit)

(4,083,771)

(5,284,181)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

$

4,995,914

$

4,437,950

See accompanying notes to consolidated financial statements.


2


Mobivity Holdings Corp.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

  

Three Months Ended

 
  

March 31,

 
  

2023

  

2022

 

Revenues

        

Revenues

 $1,881,482  $2,029,569 

Cost of revenues

  1,066,575   1,174,948 

Gross profit

  814,907   854,621 
         

Operating expenses

        

General and administrative

  1,544,106   1,207,176 

Sales and marketing

  691,220   597,501 

Engineering, research, and development

  734,375   702,223 

Depreciation and amortization

  63,902   124,312 

Total operating expenses

  3,033,603   2,631,212 
         

Loss from operations

  (2,218,696)  (1,776,591)
         

Other income/(expense)

        

Loss of settlement of debt

  (10,857)   

Interest expense

  (238,446)  (159,827)

Settlement Losses

  (10,000)   

Foreign currency gain

  (176)  3,319 

Total other income/(expense)

  (259,479)  (156,508)

Loss before income taxes

  (2,478,175)  (1,933,099)

Income tax expense

      

Net loss

  (2,478,175)  (1,933,099)

Other comprehensive income (loss), net of income tax

        

Foreign currency translation adjustments

  31,502   (12,895)

Comprehensive loss

 $(2,446,673) $(1,945,994)

Net loss per share:

        

Basic and Diluted

  (0.04)  (0.03)

Weighted average number of shares:

        

Basic and Diluted

  62,078,218   57,233,309 

Three Months Ended

March 31,

2022

2021

Revenues

Revenues

$

2,029,569

$

2,457,590

Cost of revenues

1,174,948

1,041,795

Gross profit

854,621

1,415,795

Operating expenses

General and administrative

1,207,176

1,289,370

Sales and marketing

597,501

896,750

Engineering, research, and development

702,223

723,950

Impairment of intangible asset

8,286

Depreciation and amortization

124,312

158,227

Total operating expenses

2,631,212

3,076,583

Loss from operations

(1,776,591)

(1,660,788)

Other income/(expense)

Interest income

5

Interest expense

(159,827)

(32,516)

Foreign currency gain (loss)

3,319

(474)

Total other income/(expense)

(156,508)

(32,985)

Loss before income taxes

(1,933,099)

(1,693,773)

Income tax expense

Net loss:

(1,933,099)

(1,693,773)

Other comprehensive loss, net of income tax

Foreign currency translation adjustments

(12,895)

(9,678)

Comprehensive loss

$

(1,945,994)

$

(1,703,451)

Net loss per share:

Basic and Diluted

$

(0.03)

$

(0.03)

Weighted average number of shares:

Basic and Diluted

57,233,309

55,410,695

See accompanying notes to consolidated financial statements (unaudited).


3


Mobivity Holdings Corp.

Condensed Consolidated Statement of Stockholders’ Equity (Deficit)

(Unaudited)

Common Stock

Equity

Additional

Accumulated Other

Accumulated

Total Stockholders'

Shares

Dollars

Payable

Paid-in Capital

Comprehensive Loss

Deficit

Equity (Deficit)

Balance, December 31, 2020

55,410,695

$

55,411

$

100,862

101,186,889

$

(23,446)

(99,575,503)

1,744,213

Stock based compensation

228,623

228,623

Foreign currency translation adjustment

(9,678)

(9,678)

Net loss

(1,693,773)

(1,693,773)

Balance, March 31, 2021

55,410,695

$

55,411

$

100,862

$

101,415,512

$

(33,124)

$

(101,269,276)

$

269,385

Common Stock

Equity

Additional

Accumulated Other

Accumulated

Total Stockholders'

Shares

Dollars

Payable

Paid-in Capital

Comprehensive Loss

Deficit

Equity (Deficit)

Balance, December 31, 2021

55,410,695

$

55,411

$

100,862

$

102,446,921

$

(52,088)

$

(107,835,287)

$

(5,284,181)

Issuance of common stock for warrant exercise

3,188,190

$

3,188

$

2,547,365

$

$

$

2,550,553

Fair value of options issued with related party lue of debt

6,201

6,201

Stock based compensation

589,650

589,650

Foreign currency translation adjustment

(12,895)

(12,895)

Net loss

(1,933,099)

(1,933,099)

Balance, March 31, 2022

58,598,885

$

58,599

$

100,862

$

105,590,137

$

(64,983)

$

(109,768,386)

$

(4,083,771)

See accompanying notes to consolidated financial statements (unaudited).

See accompanying notes to consolidated financial statements (unaudited).


4

2

Mobivity Holdings Corp.

Condensed Consolidated Statement of Stockholders Equity (Deficit)

(Unaudited)

  

Common Stock

  

Equity

  

Additional Paid-in

  

Accumulated Other Comprehensive

  

Accumulated

  

Total Stockholders' Equity

 
  

Shares

  

Dollars

  

Payable

  

Capital

  

Loss

  

Deficit

  

(Deficit)

 

Balance, December 31, 2021

  55,410,695  $55,411  $100,862  $102,446,921  $(52,088) $(107,835,287) $(5,284,181)

Issuance of common stock for warrant exercise

  3,188,190   3,188      2,547,365         2,550,553 

Fair value of options issued with related party debt

           6,201  $  $  $6,201 

Stock based compensation

           589,650         589,650 

Foreign currency translation adjustment

              (12,895)     (12,895)

Net loss

                 (1,933,099)  (1,933,099)

Balance, March 31, 2022

  58,598,885  $58,599  $100,862  $105,590,137  $(64,983) $(109,768,386) $(4,083,771)

  

Common Stock

  

Equity

  

Additional Paid-in

  

Accumulated Other Comprehensive

  

Accumulated

  

Total Stockholders' Equity

 
  Shares  Dollars  Payable  Capital  Loss  Deficit  (Deficit) 

Balance, December 31, 2022

  61,311,155  $61,311  $324,799  $108,806,353  $(100,963) $(117,896,409) $(8,804,909)

Issuance of common stock for warrant exercise

  3,587,487   3,587      3,583,900         3,587,487 

Issuance of common stock for Settlement of Interest Payable on Related Party Debt

  163,757   164   (7,713)  223,773         216,223 

RSU's issued - termination of a director's service

  545,012   

545

      (545)         

Stock based compensation

           810,157         810,157 

Foreign currency translation adjustment

              31,502      31,502 

Net loss

                 (2,478,175)  (2,478,175)

Balance, March 31, 2023

  65,607,411  $65,607  $317,086  $113,423,638  $(69,461) $(120,374,584) $(6,637,714)

See accompanying notes to consolidated financial statements (unaudited).

3

Mobivity Holdings Corp.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

  

Three Months Ended

 
  

March 31,

 
  

2023

  

2022

 

OPERATING ACTIVITIES

        

Net loss

 $(2,478,175) $(1,933,099)

Adjustments to reconcile net loss to net cash used in operating activities:

        

Loss on Settlement of Debt - related party

  10,857    

Bad debt expense

  (10,576)  (10,705)

Stock-based compensation

  810,157   589,650 

Depreciation and amortization expense

  63,902   124,312 

Amortization of Debt Discount

  31,567   24,205 

Increase (decrease) in cash resulting from changes in:

        

Accounts receivable

  341,773   98,004 

Other current assets

  (17,891)  (105,749)

Operating lease assets/liabilities

  (9,680)  2,822 

Other assets

  (3,423)   

Accounts payable

  (76,695)  (320,445)

Accrued interest

  204,188   133,125 

Accrued and deferred personnel compensation

  (77,402)  (203,103)

Other liabilities - current

  (34,079)   

Other liabilities - non current

     (9,071)

Deferred revenue and customer deposits

  (197,987)  (203,791)

Net cash used in operating activities

 $(1,443,464) $(1,813,845)
         

INVESTING ACTIVITIES

        

Purchases of equipment

  (14,111)   

Net cash used in investing activities

  (14,111)   
         

FINANCING ACTIVITIES

        

Payments on notes payable

  (9,978)  (6,354)

Proceeds from conversion of common stock warrants

  3,587,487   2,550,553 

Net cash provided by financing activities

  3,577,509   2,544,199 
         

Effect of foreign currency translation on cash flow

  34,923   (10,631)
         

Net Change in cash

  2,154,857   719,723 

Cash at beginning of period

 $426,740  $735,424 

Cash at end of period

  2,581,597   1,455,147 
         
         

Non cash investing and financing analysis:

        

Interest Paid

 $  $ 
         

Fair Value of Options issued with related party debt

 $  $6,201 

Shares issued for settlement of debt - related party

 $205,367  $ 

Shares issued from stock payable for settlement of debt - related party

 $223,937  $ 
Par Value of stock for RSU's issued - termination of director's service $

545

  $

 —

 

Three Months Ended

March 31,

2022

2021

OPERATING ACTIVITIES

Net loss

$

(1,933,099)

$

(1,693,773)

Adjustments to reconcile net loss to net cash used in operating activities:

Bad debt expense

(10,705)

11,297

Stock-based compensation

589,650

228,623

Intangible asset impairment

8,286

Depreciation and amortization expense

124,312

141,591

Amortization of Debt Discount

24,205

Increase (decrease) in cash resulting from changes in:

Accounts receivable

98,004

(1,071,359)

Other current assets

(105,749)

(70,901)

Operating lease assets/liabilities

2,822

16,636

Contracts receivable, long-term

235,976

Other assets

(108,652)

Accounts payable

(320,445)

308,399

Accrued interest

133,125

(15,775)

Accrued and deferred personnel compensation

(203,103)

248,828

Other liabilities - non-current

(9,071)

(138,589)

Other liabilities - current

(36,130)

Deferred revenue and customer deposits

(203,791)

33,584

Net cash used in operating activities

(1,813,845)

(1,901,959)

INVESTING ACTIVITIES

Purchases of equipment

(75,852)

Capitalized software development costs

(50,588)

Net cash used in investing activities

(126,440)

FINANCING ACTIVITIES

Payments on notes payable

(6,354)

(141,058)

Payments on related party notes payable

(80,000)

Proceeds from conversion of common stock warrants

2,550,553

Net cash provided by (used in) financing activities

2,544,199

(221,058)

Effect of foreign currency translation on cash flow

(10,631)

(6,155)

Net change in cash

719,723

(2,255,612)

Cash at beginning of period

735,424

3,282,820

Cash at end of period

$

1,455,147

$

1,027,208

Supplemental disclosures:

Cash paid during period for:

Interest

$

$

29,541

Non Cash investing and financing analysis:

Fair Value of Options issued with related party debt

$

6,201

$

Fixed Asset Contributed by Lessor

110,000

Initial ROU and asset and least liability

1,458,527

See accompanying notes to consolidated financial statements.

5

4

See accompanying notes to consolidated financial statements.


6


Mobivity Holdings Corp.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Nature of Operations and Basis of Presentation

Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands, and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14,2018, we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable, and intellectual property. We generate revenue by charging the resellers, brands, and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q10-Q and Rule 8-038-03 of Regulation S-XS-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K10-K for the year ended December 31, 2021 2022filed with the SEC on March 30,2022.

In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of our condensed consolidated financial statements as of March 31, 2022,2023, and for the three months ended March 31, 2022 2023 and 2021.2022. The results of operations for the three months ended March 31, 20222023 are not necessarily indicative of the operating results for the full year ending December 31, 2022.2023.

2. Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.

Reclassifications

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect ondid not affect previously reported net loss.losses.

Acquisitions

Acquisitions

We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.

Cash and Cash Equivalents

Cash

We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.

7


Accounts Receivable, Allowance for Doubtful Accounts and Concentrations

Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate.

As of March 31, 2022,2023, and December 31, 2021,2022, we recorded an allowance for doubtful accounts of $53,514$10,820 and $56,340,$34,446 respectively.

Goodwill and Intangible Assets

Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than it’sits carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.

5

We conducted our annual impairment tests of goodwill as of December 31, 2021.2022. As a result of these tests, we had a total impairment chargescharge of $85,169.$963,659.

Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year to twenty years. No significant residual value is estimated for intangible assets.

The Company’s evaluation of its long-livedgoodwill and intangible assets completed resulted in $0 and $8,286 of intangibleno impairment expense duringcharges for the quartersthree months ended ended March 31, 20222023 and March 31, 2021.2022, respectively.

Software Development Costs

Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASBFinancial Accounting Standards Board ("FASB") guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC(Accounting Standards Codification subtopic 985-20, Costs of Software to Be Sold, Leased, or Marketed, or “ASC Subtopic 985-20”985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. TechnologicalThe technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense.

Capitalized costs for those products that are cancelledcanceled or abandoned are charged to product development expenseexpenses in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month-month period.

The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer.Thecustomer. The Company’s evaluation of its capitalized software development assetassets resulted in no impairment charges of $0 for the quarterthree months ended March 31, 20222023 and $0 for the year ended December 31, 2021..2022, respectively

Impairment of Long-Lived Assets

We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.

8


Foreign Currency Translation

The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards CodificationASC subtopic 830-10, 830-10,Foreign Currency Matters (“ASC 830-10”830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income.

Revenue Recognition and Concentrations

Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and fees are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue.

Accounting Standards Update (“ASU”) No. 2014-09,2014-09, Revenue from Contracts with Customers (Accounting Standards Codification 606 (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1,2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues.

We determine revenue recognition under ASC 606 through the following steps:

identification of the contract, or contracts, with a customer;

identification of the performance obligations in the contract;

identification of the transaction price;

allocation of the transaction price to the performance obligations in the contract; and

recognition of revenue when, or as, we satisfy a performance obligation.

identification of the contract, or contracts, with a customer;

identification of the performance obligations in the contract;

identification of the transaction price;

allocation of the transaction price to the performance obligations in the contract; and

recognition of revenue when, or as, we satisfy a performance obligation.

During the three months ended March 31, 2022 2023 and 2021, 22022, two customers accounted for 53%51% and 64%53% of our revenues, respectively.

6

Comprehensive Income (Loss)

Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at a comprehensive loss. For the three months ended March 31,, 2022 2023 and 2021,2022, the comprehensive loss was $2,446,673, and $1,945,994 and $1,703,451 respectively.

Stock-based Compensation

We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.

Research and Development Expenditures

Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.

Advertising Expense

9


Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements,trade shows, sales enablement, content creation, paid engagement and other direct costs. Advertising expense was $163,734$54,248 and $188,343$163,734 for the three months ended March 31, 2022 2023 and 2021,2022, respectively. We also include the cost of attending trade shows under marketing expense. We recorded $10,000 and $0 of expense related to those activities for the three months ended March 31, 2022 and 2021, respectively.

Income Taxes

We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.

Net Loss Per Common Share

Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase, and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three months ended March 31, 2022 2023 and 2021,2022, we had securities outstanding which could potentially dilute basic earnings per share in the future. ThoseStock based compensation, stock options and warrants were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive.

Recent Accounting Pronouncements

Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following areis a summary of recent accounting developments.

In August 2020, the FASB issued ASU 2020-06,2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06” or the “ASU”2020-06”). ASU No. 2020-062020-06 requires that the if-converted method of computing diluted Earnings per Share. The companyCompany adopted ASU 2020-06 on January 1,2022.

10


3. Going Concern

We have $1,455,147had $2,581,597 of cash as of March 31, 2022.2023. We had a net loss of $1.9 million$2,478,175 for the quarter thenthree months endedMarch 31, 2023, and we used $1.8 million$1,443,464 of cash in our operating activities during that time. In the quarterthree months ended March 31, 2022. In 2021,2022 we had a net loss of $8.3 million$1,933,099 and used $4.5 million$1,813,845 of cash in our operating expenses. We raised $2,550,553$3.6 million in cash from the exercise of warrants in February 2022.of 2023. There is substantial doubt that our additional cash from our warrant conversion along with our expected cash flow from operations, will not be sufficient to fund our 12-month12-month plan of operations, there can be no assurance that we will not require significant additional capital within 12 months.

As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $109,768,386$120.4 million as of March 31, 2022.2023. Further losses are anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve12 months with the proceeds from the sale of securities, and/or revenues from operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

7

4. Goodwill and Purchased Intangibles

Goodwill

The carrying value of goodwill at each of March 31, 20222023 and December 31, 20212022 was $411,183.$0.

The following table presents details of our purchased intangible assets as of March 31, 20222023 and December 31, 2021:2022:

Intangible assets

  Balance at December 31, 2022  

Additions

  

Impairments

  

Amortization

  

Fx and Other

  Balance at March 31, 2023 

Patents and trademarks

 $52,698  $  $  $(1,223) $3  $51,475 

Customer and merchant relationships

  30,690        $(6,138)     24,552 

Trade names

  8,050        $(1,609)     6,441 
  $91,438  $  $  $(8,970) $3  $82,468 

Balance at December 31, 2021

Additions

Impairments

Amortization

Fx and Other

Balance at
March 31,
2022

Patents and trademarks

$

57,595

$

$

$

(4,376)

$

3,147

$

56,366

Customer and merchant relationships

545,533

(24,213)

521,320

Trade name

32,393

(2,259)

30,134

Acquired technology

112,191

(4,075)

108,116

Non-compete agreements

29,212

(3,965)

25,247

$

776,924

$

$

$

(38,888)

$

3,147

$

741,183

The intangible assets are being amortized on a straight-line basis over their estimated useful lives of one year to twenty years.

Amortization expense for intangible assets was $38,888$8,970 and $36,004$38,888 for the three months ended March 31, 202 2023 and 2021,2022, respectively.

The estimated future amortization expense of our intangible assets as of March 31, 20222023 is as follows:

Year ending December 31,

 

Amount

 

2023

 $26,913 

2024

  12,639 

2025

  4,891 

2026

  4,891 

2027

  4,891 

Thereafter

  28,243 

Total

 $82,468 

Year ending December 31,

Amount

2022

$

111,085

2023

145,606

2024

109,009

2025

101,261

2026

101,261

Thereafter

172,961

Total

$

741,183

11


4.5. Software Development Costs

The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activitiesactivities.

The following table presents details of our software development costs as of March 31, 20222023 and December 31, 2021:2022:

  Balance at December 31, 2022  

Additions

  

Amortization

  Balance at March 31, 2023 

Software Development Costs

 $103,334  $  $(41,945) $61,389 
  $103,334  $  $(41,945) $61,389 

Balance at

December 31,

2021

Additions

Amortization

Balance at

March 31,

2022

Software Development Costs

$

347,796

$

$

(73,289)

$

274,507

$

347,796

$

$

(73,289)

$

274,507

Software development costs are being amortized on a straight-line basis over their estimated useful life of two years.

8

Amortization expense for software development costs was $73,289$41,945 and $99,209$73,289 for the three months ended March 31, 2022 2023 and 2021,2022, respectively.

The estimated future amortization expense of software development costs as of March 31, 20222023 is as follows:

Year ending December 31,

 

Amount

 

2023

 $56,884 

2024

  4,505 

2025

   

2026

   

2027

   

Thereafter

   

Total

 $61,389 

Year ending December 31,

Amount

2022

$

182,021

2023

92,161

2024

325

2025

2026

Thereafter

Total

$

274,507

5.6. Operating Lease Assets

The Company entered into a lease agreement on February 1,2021, for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $25,953 to $28,733. The firsttwelve months of the lease includesincluded a 50% abatement period and a deposit forof $110,000 was required. The lessor contributed $110,000 towards the purchase of office furniture as part of the lease agreement. As of March 31, 2022,2023, we have an operating lease asset balance of $1,132,317$930,658 and an operating lease liability balance of $1,365,431$1,127,671 recorded in accordance with ASC 842.842, Leases (ASC "842").

The following are additional details related to leases recorded on our balance sheet as of March 31, 2022:2023:

Leases

Classification

 Balance at March 31, 2023 

Assets

     

Current

     

Operating lease assets

Operating lease assets

 $ 

Noncurrent

     

Operating lease assets

Noncurrent operating lease assets

 $930,658 

Total lease assets

 $930,658 
      

Liabilities

     

Current

     

Operating lease liabilities

Operating lease liabilities

 $257,614 

Noncurrent

     

Operating lease liabilities

Noncurrent operating lease liabilities

 $870,057 

Total lease liabilities

 $1,127,671 

Leases

Classification

Balance at

March 31,

2022

Assets

Current

Operating lease assets

Operating lease assets

$

Noncurrent

Operating lease assets

Noncurrent operating lease assets

$

1,132,317

Total lease assets

$

1,132,317

Liabilities

Current

Operating lease liabilities

Operating lease liabilities

$

237,761

Noncurrent

Operating lease liabilities

Noncurrent operating lease liabilities

$

1,127,670

Total lease liabilities

$

1,365,431

12

9

The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term, and weighted average discount rate:

Year ending December 31,

    

2023

 $243,583 

2024

  330,894 

2025

  337,568 

2026

  344,241 

2027

  28,733 

Thereafter

   

Total future lease payments

  1,285,019 

Less: imputed interest

  (157,348)

Total

 $1,127,671 

Year ending December 31,

Amount

2022

$

241,949

2023

324,221

2024

330,894

2025

337,568

2026

344,241

Thereafter

28,733

Total future lease payments

1,607,606

   Less: imputed interest

(242,175)

Total

$

1,365,431

Weighted Average Remaining Lease Term (years)

Operating leases

5.6

3.83

Weighted Average Discount Rate

Operating leases

6.75%

6.75%

6.7. Notes Payable and Interest Expense

The following table presents details of our notes payable as of March 31, 20222023 and December 31, 2021:2022:

Facility

 

Maturity

 

Interest Rate

  Balance at March 31, 2023  Balance at December 31, 2022 

ACOA Note

 

February 1, 2024

     24,354   34,231 

TD Bank

 

December 31, 2023

     29,565   29,478 

Related Party Note

 

various

  15%  5,224,028   5,192,461 

Total Debt

      5,277,947   5,256,170 

Less current portion

      (1,351,619)  (2,743,788)

Long-term debt, net of current portion

     $3,926,328  $2,512,382 

Facility

Maturity

Interest Rate

Balance at
March 31,
2022

Balance at Dcember 31, 2021

ACOA Note

February 1, 2024

71,389

76,642

TD Bank

December 31, 2022

31,982

31,496

Related Party Note

various

15%

3,336,246

3,318,242

Total Debt

3,439,617

3,426,380

Less current portion

1,520,744

888,583

Long-term debt, net of current portion

$

1,918,873

$

2,537,797

ACOA Note

On November 6,2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2,2014, with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement, the note will mature, and the commitments will terminate on February 1,2024. The monthly principal payment amount of $3,000 CAD increased to $3,500 CAD beginning on November 1,2019, $4,000 CAD on August 1,2021, $4,500 CAD on August 1,2022, and $2,215 CAD during the remaining term of the agreement. Payments from April-December April- December of 2020 were voluntarily deferred by ACOA due to COVID-19. COVID-19.

During the three months ended March 31, 20222023 we repaid $6,554$9,878 USD of principal.

TD Bank Loan

On April 22,2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $40,000 CAD, which is due and payable on December 31, 2022.2023. This note bears interest on the unpaid balance at the rate of 0zero percent (0%) per annum during the initial term. Under this note, 0no interest or principal payments are due until January 1, December 31,2023. Under the conditions of the loan, NaNthirty-three percent (25%(33%) of the loan will be forgiven if NaNsixty-seven percent (75%(67%) is repaid prior to the initial term date.

Related Party Notes

Secured Promissory Notes

On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $200,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of 15 percent (15%) per annum. The Company may prepay this Note without notice, subject to a 2 percent (2%) pre-payment penalty.

13


On November 18, 2020, we issued 2 additional unsecured Notes in the principle aggregate amount of $500,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of 15 percent (15%) per annum. The Company may prepay this Note without notice, subject to a 2 percent (2%) pre-payment penalty.

On December 31, 2020 $1,200,000 of these Notes and the accrued interest of $192,208 was settled into equity and we recorded a loss on settlement of debt of $668,260 for the year ended December 31, 2020. In summary, as of December 31, 2020, we have a principal balance of $580,000 and accrued interest of $42,492 outstanding.

On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with Thomas Akin, one of the Company’s directors. directors (the "Lender"). The Credit Agreement was amended on November 11, 2022. The Company can borrow up to $3,500,000 under this Credit Agreement. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. As of December 31, 2021, the company has drawn a total of $3,478,125 including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest$6,000,000 under the above-described Note that was rolled into Credit Agreement ("the "Credit Facility").

The Credit Facility. As of December 31, 2021, we have accrued interest of $149,040. The loanFacility is secured by all of our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. This loan bears interest on the unpaid balance at the rate of 15fifteen percent (15%) per annum. The Company may prepay this Noteloan without notice, penalty, or charge. In consideration of the lender’sLender’s agreement to provide the facility,Credit Facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under thisthe Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the corresponding notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lenderLender additional warrants entitling the lenderLender to purchase a number of shares of the CompanyCompany's common stock equal to 20twenty percent (20%) of the amount of the advances made divided by the volume weightedvolume-weighted average price over the 30 trading days preceding the advance (VWAP)(the "VWAP"). Each warrant will be exercisable over a three year-year period at an exercise price equal to the VWAP.

DuringUnder the twelveoriginal terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. On November 11, 2022, an amendment to the Credit Agreement was signed. The amendment updated the payment terms to the following: "Without limiting the foregoing Section 2.3(a), Borrower shall repay the principal amount of all Advances, plus accrued interest thereon, in 24 equal monthly installments commencing on January 31, 2023 and continuing thereafter on the last day of each month period ending (or, if such last day is not a Business Day, on the Business Day immediately preceding such last day. Interest on the unpaid Advances will accrue from the date of each Advance at a rate equal to fifteen percent (15%) per annum. Interest will be calculated on the basis of 365 days in a year." The amendment raised the maximum amount of the Credit Facility to $6,000,000. In addition, the interest which is accrued monthly between July 1, 2022, and December 31, 2021, 2022, will be settled into equity. Common Stock will be issued at the end of each month at a rate of $1.08 per share of common stock in the amount of the interest accrued for each month.

On January 31, 2023, the Company entered into Amendment No.1 (the “Amendment”) to the Amended and Restated Credit Facility Agreement and Convertible Notes which amends our existing Amended and Restated Credit Facility Agreement, dated as of November 11, 2022, between the Company and Thomas B. Akin, a director of the Company (the “Existing Credit Agreement” and as amended by the Amendment, the “Credit Agreement”) and any convertible notes issued warrantsthereunder. The Amendment amends the Existing Credit Agreement to purchase an aggregateextend the maturity of 600,570the Credit Agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025, and further provides that any accrued interest on unpaid advances under the Credit Agreement is to be paid quarterly in shares of itsour common stock, at the stated exercisea price per share equal to the volume-weighted average price of our common stock quoted on the OTCQB® Venture Market operated by OTC Markets Group Inc. over the ninety (90) trading days immediately preceding such date. The Amendment provides for corresponding amendments to the form of convertible note to be issued under the Credit Agreement in connection withthe future and any outstanding convertible notes issued under the Existing Credit Agreement.

During the three months ended March 31, 2023, a total of $195,171 of interest was accrued and settled to equity payable for the issuance of funds under this Credit Agreement.180,715 shares of common stock. The estimated aggregate fair valuecompany recorded a loss of settlement of interest payable of $10,315 . The company issued 154,106 shares from equity payable related to accrued interest settled during the warrants issued is $262,758 using fourth quarter of 2022.

As of March 31, 2023, the Black-Scholes option valuation model asCompany had drawn a total of December 31, 2021.$5,173,125 and we have accrued interest of $387,918. 

Unsecured Promissory Note

On July 1, 2021, we entered into an Unsecured PromissoryUP Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $271,875 to certain investors, officerswith Talkot Fund, LP and directors ofinvestor in the Company. Each UP Note bears interest on the unpaid balance at the rate of 15fifteen percent (15%) per annum and the principal and accrued interest isare due and payable no later than July 1,December 31, 2023. We may prepay any of the UP Notes without notice, subject to a 2two percent (2%) pre-payment penalty. The UP Note offer was conducted by our management and there were 0no commissions paid by us in connection with the solicitation. The Company issued to Talkot Fund LP warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement.UP Note.

On January 31, 2023, the Lender agreed to postpone the 24-month repayment period to a later period commencing on January 31, 2024, and further agreed that interest accrued on the loan between July 1, 2022 and December 01, 2025 is to be settled in shares of the Company’s common stock quarterly.

During the twelve month period ending Decemberthree months ended March 31, 2021,2023, a total of $10,196 of interest was accrued and settled to equity payable for the issuance of 9,441 shares of common stock. The company recorded a loss of settlement of interest payable of $542 . The company issued 9,651 shares from equity payable related to accrued interest settled during the fourth quarter of 2022.

As of March 31,2023, the Company had a principal balance of $271,875, and accrued interest of $54,351.  

Interest Expense

Interest expense was $238,446 and $159,827 during the three months ended March 31, 2023 and 2022, respectively.

10

8. Stockholders Equity

Common Stock and Equity Payable

2022

On February 9,2022, 17 warrant holders exercised their common stock purchase warrant for 3,188,190 shares at the exercise price of $0.80 per share, resulting in additional capital of $2,550,552. As an inducement for the holders' exercise of the warrants, we issued the holders 3,188,190 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in February 2025. We have recorded an aggregateadditional stock-based expense of 600,570$382,048 in 1st quarter of 2022.

On June 29, 2022, the Company received private investment funds to purchase 1,062,500 shares of its common stock at the stated exercisea price of  $0.80 per share, resulting in connection withadditional capital of $850,000, and issued the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $286,296 using the Black-Scholes option valuation model as of March 31, 2022.

During the three month period ending March 31, 2021, the Company issuedholders 1,062,500 new warrants to purchase an aggregate of 20,339common stock at $1.50 per share over a three-year period expiring in June 2025.

On August 24,2022, the Company received private investment funds to purchase 1,500,000 shares of its common stock at the stated exercisea price of $0.80 per share, resulting in connection withadditional capital of $1,200,000, and issued the holders 1,500,000 new warrants to purchase common stock at $1.50 per share over a three year period expiring in August  2025.

On November 13, 2022 a total of 140,185 shares of common stock were issued from equity payable to Thomas Akin as settlement of $151,398 of interest payable. The Company recorded a loss on settlement of interest payable of $2,259.

On November 13, 2022 a total of 9,585 shares of common stock were issued from equity payable to Talkot Fund LP as settlement of $10,352 of interest payable. The Company recorded a loss on settlement of interest payable of $162.

On December 31, 2022 a total of $166,432 of interest was accrued and settled to equity payable for the issuance of funds under this Credit Agreement.154,106 shares of common stock. The company recorded a loss of settlement of interest payable of $44,325.

On December 31, 2022 a total of $10,423 of interest was accrued and settled to equity payable for the issuance of 9,651 shares of common stock. The company recorded a loss of settlement of interest payable of $2,757,

2023

On January 31, 2023 a total of 545,012 shares were issued to John Harris, a former director. The shares were issued based on the total Restricted Stock Units earned by Mr. Harris as director compensation that were fully vested as of March 29, 2022. Restricted stock expense is recorded on the date it vests and no expense was recognized during the three months ended March 31, 2023.

On March 27, 2023 a total of 154,106 shares of common stock were granted from equity payable to Thomas Akin as settlement of $166,432 of interest payable. The Company recorded a loss on settlement of interest payable of $44,325 on December 31, 2022.

On March 27, 2023 a total of 9,651 shares of common stock were granted from equity payable to Talkot Fund LP as settlement of $10,423 of interest payable. The Company recorded a loss on settlement of interest payable of $2,757 on December 31, 2022.

On March 31, 2023 a total of $195,171 of interest was accrued and settled to equity payable for the issuance of 180,715 shares of common stock. The company recorded a loss of settlement of interest payable of $10,315.

On March 31, 2023 a total of $10,196 of interest was accrued and settled to equity payable for the issuance of 9,441 shares of common stock. The company recorded a loss of settlement of interest payable of $542.

During March, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders' 1,793,745 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in  February 2025. The Company recorded $577,000 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated aggregate fair value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

During the three months ended March 31, 2023 a total of 163,757 shares were issued is 6,201from stock payable related to related party accrued interest settled during the fourth quarter of 2022.

As of the March 31, 2023 we had an equity payable balance of $317,086.

Stock-based Plans

Stock Option Activity

The following table summarizes stock option activity for the three months ended March 31, 2023.

Options

Outstanding at December 31, 2021

6,246,466

Granted

1,375,000

Exercised

Forfeited/canceled

(330,623)

Expired

(599,627)

Outstanding at December 31, 2022

6,691,216

Granted

Exercised

Forfeited/canceled

(72,916)

Expired

(29,030)

Outstanding at March 31, 2023

6,589,270

2022

On March 29,2022, the Company granted one employee 150,000 options to purchase shares of the Company's common stock at the closing price as of March 29,2022, of $0.8289 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until March 29,2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 72.33% and an option fair value of $0.54 was $81,035.

On May 16, 2022, the Company granted three employees 45,000 options to purchase shares of the Company's common stock at the closing price as of May 16, 2022, of $0.97 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until May 16, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.45% and an option fair value of $0.642608 was $28,917.

On September 22, 2022, the Company granted one employee 1,000,000 options to purchase shares of the Company's common stock at the closing price as of September 2022, of $0.98 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until September 29, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 76.15% and an option fair value of $0.697499 was $697,499.

2023

During the three months ended March 31, 2023 no options were granted.

11

Stock-Based Compensation Expense from Stock Options and Warrants

The impact on our results of operations of recording stock-based compensation expense for the three months ended March 31, 2023 and 2022 were as follows:

  

Three Months Ended

 
  

March 31,

 
  

2023

  

2022

 

General and administrative

 $65,032  $128,246 

Sales and marketing

  68,646   12,867 

Engineering, research, and development

  34,475   66,490 
  $168,153  $207,603 

Valuation Assumptions

The fair value of each stock option award was calculated on the date of the grant using the Black-Scholes option valuation model as of pricing model. The following weighted average assumptions were used for the three months ended March 31, 2023 and 2022.

Three Months Ended

March 31,

2023

2022

Risk-free interest rate

%2.47%

Expected life (years)

6.00

Expected dividend yield

%%

Expected volatility

%72.33%

Interest ExpenseThe risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options.

Interest expenseThe expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was $159,827determined based on the historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and $32,516 duringexpectations of future employee behavior as influenced by changes to the three months ended March 31, 2022terms of the Company's stock-based awards.

The dividend yield assumption is based on our history of not paying dividends and 2021, respectively.no future expectations of dividend payouts.

7. Stockholders’ EquityThe expected volatility in 2023 and 2022 is based on the historical publicly traded price of our common stock.

Common StockRestricted stock units

2021

DuringThe following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2022 and for the three months ended March 31, 2023:

Shares

Outstanding at December 31, 2021

1,685,141

Awarded

244,792

Released

Canceled/forfeited/expired

Outstanding at December 31, 2022

1,929,933

Awarded

61,324

Released

(545,012)

Canceled/forfeited/expired

Outstanding at March 31, 2023

1,446,245

Expected to vest at March 31, 2023

1,446,245

Vested at March 31, 2023

1,446,245

Unvested at March 31, 2023

Unrecognized expense at March 31, 2023

$

2022

On March 29, 2022, the company grated granted four independent directors a total of 78,420 restricted stock units. The units were valued at $65,002 or $0.829 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15,2024, (B) a change in control of the Company, did not issue anyand (C) the termination of the director’s service with the Company.

On May 16,2022, the company grated granted four independent directors a total of 54,168 restricted stock units. The units were valued at $65,002 or $1.20 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares but,of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15,2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

On September 30, 2022, the company grated granted four independent directors a total of 65,100 restricted stock units. The units were valued at $65,002 or $ per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15,2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

On  December 31, 2022 the Company granted four independent directors a total of 47,104 restricted stock units. The units were valued at $65,004 or $1.38 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A)  December 31,2025, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

During the three months ended March 31, 2022, the Company recorded $65,002 in restricted stock expense as board compensation.

2023

On March 31, 2023, the company grated granted four independent directors a total of 61,342 restricted stock units. The units were valued at $65,002 or $1.05 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15,2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

In the three months ended March 31, 2023, the Company recorded $65,003 in restricted stock expense as board compensation.

Stock Based Compensation from Restricted Stock

The impact on our results of operations of recording stock-based compensation expense of $260,005 related tofor restricted stock units for membersthe three months ended March 31, 2023 and 2022 was as follows:

  

Three Months Ended

 
  

March 31,

 
  

2023

  

2022

 

General and administrative

 $65,003  $65,002 

Sales and marketing

 $  $ 
  $65,003  $65,002 

As of our board of directors. The company recorded stock-based compensation expense of $187,501 related toMarch 31, 2023, there was no unearned restricted stock units for employeeunit compensation.

Warrants

The following table summarizes investor warrants as of March 31, 2023 and the years ended December 31, 2022 and 2021:

  

Shares

  

Weighted Average Exercise Price

  

Weighted Average Remaining Contractual Term (Years)

 

Outstanding at December 31, 2021

  3,246,690  $2.26   3.59 

Granted

  6,089,398  $    

Exercised

  (3,188,190) $    

Canceled/forfeited/expired

    $    

Outstanding at December 31, 2022

  6,147,898  $1.45   2.27 

Granted

  1,793,745  $    

Exercised

  (3,587,487) $    

Canceled/forfeited/expired

    $    

Outstanding at March 31, 2023

  4,354,156  $1.83   2.37 

12

2022

14


2022

On February 9,2022, 17 warrant holders exercised their common stock purchase warrant for 3,188,190 shares at the exercise price of $0.80 per share, resulting in additional capital of $2,550,553. As an inducement for the holder’s exercise of the warrants, we issued the holdersholders' 3,188,190 new warrants to purchase common stock at $1.50 per share over a three year-year period expiring in February 2025 and recorded additional stock-based expense of $382,048

During the quarter ended March 31, 2022 the Company recorded stock-based compensation expense of $65,002 related to restricted stock units for members of our board of directors. The company recorded stock-based compensation expense of $207,603 related to stock units for employee compensation.

As of March 31, 2021 we had an equity payable balance of $100,862.

Stock-based Plans

Stock Option Activity

The following table summarizes stock option activity for the three months ended March 31, 2022.

Options

Outstanding at December 31, 2020

6,007,552

Granted

637,500

Exercised

Forfeit/canceled

(272,029)

Expired

(126,557)

Outstanding at December 31, 2021

6,246,466

Granted

150,000

Exercised

Forfeit/canceled

(65,000)

Expired

(10,250)

Outstanding at March 31, 2022

6,321,216

The weighted average exercise price of stock options granted during the period was $0.83 and the related weighted average grant date fair value was $0.54 per share.

2021

On March 26, 2021, the Company granted 5 employees a total of 67,500 options to purchase shares of the Company common stock at the closing price as of March 26, 2021 of $1.80 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until March 26, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.97% and an option fair value of $1.16 was $78,492.

On May 2, 2021, the Company granted 1 employee a total of 20,000 options to purchase shares of the Company common stock at the closing price as of May 2, 2021, of $1.48 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until May 2, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.79% and an option fair value of $0.93 was $18,628.

On August 11, 2021, the Company granted 1 employee a total of 5,000 options to purchase shares of the Company common stock at the closing price as of August 11, 2021, of $1.75 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until August 11, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.29% and an option fair value of $1.12 was $5,606.

2022

On March 29, 2022, the Company granted 1 employee 150,000 options to purchase shares of the Company common stock at the closing price as of March 29, 2022, of $0.8289 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until March 29, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 72.33% and an option fair value of $0.54 was $81,035.

15


Stock-Based Compensation Expense from Stock Options and Warrants

The impact on our results of operations of recording stock-based compensation expense for the three months ended March 31, 2022 and 2021 were as follows:

Three Months Ended

March 31,

2022

2021

General and administrative

$

128,246

$

84,130

Sales and marketing

12,867

32,745

Engineering, research, and development

66,490

43,052

$

207,603

$

159,927

Valuation Assumptions

The fair value of each stock option award was calculated on the date of grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the three months ended March 31, 2022 and 2021.

 

Three Months Ended

March 31,

 

2022

2021

Risk-free interest rate

2.47

%

1.01

%

Expected life (years)

6.00

6.00

Expected dividend yield

%

%

Expected volatility

72.33

%

73.97

%

The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options.

The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards.

The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts.

The expected volatility in 2022 and 2021 is based on the historical publicly traded price of our common stock.

Restricted stock units

The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2021 and for the three months ended March 31, 2022:

Shares

Outstanding at December 31, 2020

1,436,728

Awarded

654,663

Released

Canceled/forfeited/expired

(406,250)

Outstanding at December 31, 2021

1,685,141

Awarded

78,420

Released

Canceled/forfeited/expired

Outstanding at March 31, 2022

1,763,561

Expected to vest at March 31, 2022

1,763,561

Vested at March 31, 2022

1,763,561

Unvested at March 31, 2022

Unrecognized expense at March 31, 2022

$

16


2021

On March 26, 2021, the Company issued to 4 independent directors a total of 36,112 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the first quarter of 2021. The units were valued at $65,002 or $1.80 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 26, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.


17


On March 26, 2021, the Company granted to 1 employee 1,000,000 restricted shares of the Company’s Common Stock at the closing price as of March 26, 2021 of $1.80 per share. The restricted stock will vest as follows (a) 50% of the restricted shares will vest ratably over forty eight months; (b) 15% of the restricted shares will vest upon the Company achieving $25,000,000 in annualized recurring revenues as reported by totaling all contracted revenues for the trailing twelve months following the end of a reporting quarter; (c) the final 35% of the restricted shares will vest upon the Company achieving $50,000,000 in annualized recurring revenues as reported by totaling all contracted revenues for the trailing twelve months following the end of a reporting quarter. Vesting is dependent on the employee’s continued employment with the Company. All of the 1,000,000 restricted shares will include a single trigger accelerated vesting should the Company undergo a change of control after August 1, 2021. If the Company undergoes a change of control prior to August 1, 2021, 300,000 of the restricted shares would be eligible for single trigger accelerated vesting.

On May 12, 2021, the Company issued to 4 independent directors a total of 38,924 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the second quarter of 2021. The units were valued at $65,002 or $1.67 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) May 2, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

On August 11, 2021, the Company issued to 4 independent directors a total of 37,143 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the third quarter of 2021. The units were valued at $65,000 or $1.75 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) , August 11, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

On December 15, 2021, the Company granted 4 independent directors a total of 42,484 restricted stock units. The units were valued at $65,000 or $1.53 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

2022

On March 29, 2022 the company grated granted 4 independent directors a total of 78,420 restricted stock units. The units were valued at $65,002 or $0.829 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

In the three months ended March 31, 2022, the company recorded $65,002 in restricted stock units as board compensation.

Stock Based Compensation from Restricted Stock

The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three months ended March 31, 2022 and 2021 was as follows:

Three Months Ended

March 31,

2022

2021

General and administrative

$

65,002

$

65,002

Sales and marketing

$

$

3,694

$

65,002

$

68,696

As of March 31, 2022, there was 0 unearned restricted stock unit compensation.

18


Warrants

The following table summarizes investor warrant as of March 31, 2022 and the years ended for the year ended December 31, 2021 and, 2020:

Shares

Weighted
Average
Exercise
Price

Weighted
Average
Remaining
Contractual
Term (Years)

Outstanding at December 31, 2020

2,691,459

$

1.99

2.94

Granted

580,231

$

Exercised

$

Canceled/forfeited/expired

(25,000)

$

Outstanding at December 31, 2021

3,246,690

$

2.26

3.59

Granted

3,208,529

$

Exercised

(3,188,190)

$

Canceled/forfeited/expired

$

Outstanding at March 31, 2022

3,267,029

$

0.83

2.85

2020

On March 2, 2020 1 warrant holder exercised their common stock purchase warrant for 234,500 shares at the exercise price of $1.00 per share, resulting in additional capital of $234,500. In December 2020, warrant holders exercised warrants to purchase common stock at $1.25 per share. At the commencement of the December warrant exercise, there were warrants outstanding that entitled their holders to purchase 2,691,459 shares of our common stock at exercise prices of $1.25 per share. Pursuant to the offer, warrant holders exercised warrants to purchase 2,666,459 shares of our common stock, resulting in additional capital of $3,333,074. As part of the exercise, 2,666,459 new warrants were issued to purchase common stock at $2.00 per share within three years.

2021

On June 30, 2021, the company issued warrants to purchase an aggregate of 227,994 shares of its common stock at an exercise price of $1.67 per share for 119,760 inducement warrants and VWAP for 108,234 additional warrants in connection with the issuance of a loan by a related party. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. The estimated aggregate fair value of the warrants issued is $119,103 using the Black-Scholes option valuation model.

On August 11, 2021 the company issued warrants of in connection with loan by related party VWAP for 10,072 additional warrants in connection with the issuance of a loan by a related party. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. The estimated aggregate fair value of the warrants issued is $5,285 using the Black-Scholes option valuation model

As of September 30, 2021, we have outstanding warrants to purchase 2,666,459 shares of common stock at $2.06 per share. These warrants expire in 2023. We also have outstanding warrants to purchase 238,066 shares of common stock at stated price per share in connection with the issuance of a loan with a related party. These warrants expire in 2024.

2022

On February 9, 2022 17 warrant holders exercised their common stock purchase warrant for 3,188,190 shares at the exercise price of $0.80 per share, resulting in additional capital of $2,550,553. As an inducement for the holder’s exercise of the warrants, we issued the holders 3,188,190 new warrants to purchase common stock at $1.50 per share over a three year period expiring in February 2025.

19


During the quarter ended March 31, 2021 he companyThe Company recorded $382,048 of stock-based expense related to warrants issued during the warrant conversion offer on February 9, 2022.

On June 29, 2022, six private investors purchased 1,062,500 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in June 2025, and 1,062,500 shares at the exercise price of $0.80 per share, resulting in additional capital of $850,000. 

On August 24, 2022, five private investors purchased 1,500,000 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in August 2025, and 1,500,000 shares at the exercise price of $0.80 per share, resulting in additional capital of $1,200,000. 

During the three months ended March 31, 2023, the Company issued warrants to purchase an aggregate of 177,571 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under the Credit Agreement. The estimated aggregate fair value of the warrants issued is $73,469 using the Black-Scholes option valuation model as of March 31, 2023.

2023

During the three months ended March 30, 2023, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders 1,793,745 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in  February 2025. The Company recorded $577,000 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

8.

9. Fair Value Measurements

Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-tierthree-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1)1) observable inputs such as quoted prices in active markets; (Level 2)2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3)3) unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. This hierarchy requires companies to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, we measure certain financial assets and liabilities at fair value.

The following table presents assets that are measured and recognized at fair value as of March 31, 20222023 on a recurring and non-recurring basis:

Description

 

Level 1

  

Level 2

  

Level 3

  

Gains (Losses)

 

Goodwill (non-recurring)

 $  $  $  $ 

Intangibles, net (non-recurring)

 $  $  $143,857  $ 

Description

Level 1

Level 2

Level 3

Gains (Losses)

Goodwill (non-recurring)

$

$

$

411,183

$

Intangibles, net (non-recurring)

$

$

$

1,015,690

$

The following table presents assets that are measured and recognized at fair value as of December 31, 20212022 on a recurring and non-recurring basis:

Description

 

Level 1

  

Level 2

  

Level 3

  

Gains (Losses)

 

Goodwill (non-recurring)

 $  $  $  $ 

Intangibles, net (non-recurring)

 $  $  $194,772  $ 

Description

Level 1

Level 2

Level 3

Gains (Losses)

Goodwill (non-recurring)

$

$

$

411,183

$

Intangibles, net (non-recurring)

$

$

$

1,124,720

$

9.10. Commitments and Contingencies

Litigation

As of the date of this report, there are nothe company has one pending legal proceedingsproceeding related to which we orTCPA (Telephone Consumer Protection Act) Violation. This is a putative class action complaint alleging that Defendant initiated telephone solicitations through text messages in violation of the Florida Telephone Solicitation Act, Fla. Stat. §501.059 (“FTSA”). The defense of the matter was tendered to the Company by its client, Sonic Industries, Inc., and our properties are subject, except for routine litigation incurredfirm is managing the defense of the matter. The Company intends to seek an individual settlement of the matter, and if one cannot be reached, the Company intends to vigorously defend the matter. The discovery process has not begun so it is not possible at this time to calculate an accurate assessment of the Company’s exposure. No settlement loss has been accrued as it is too early in the normal courseproceedings estimate what it if any settlement loss will occur.

During the three months ended March 31, 2023 the Company has settled three TCPA claims for a total settlement loss of business.$10,000.

Operating Lease

As described in Note 5,6, the Company has a lease agreement for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $25,953 to $28,733. The first twelve12 months of the lease includesincluded a 50% abatement period. As of March 31, 2022,2023, we have an operating lease asset balance for this lease of $1,129,679$930,658 and an operating lease liability balance for this lease of  $1,362,079$1,127,671 recorded in accordance with ASC 842842.

The Company also has a lease through April 2022 for 3,248 square feet of office space located in Halifax, Nova Scotia, at a monthly rental expense of $2,665 to $3,371 per month, excluding common area maintenance charges. As of March 31, 2022, we have an operating lease asset balance for this lease of $2,638 and an operating lease liability balance for this lease of $3,352 recorded in accordance with ASC 842.

20

13

10.11. Related Party Transactions

Secured Notes

On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with Thomas Akin, one of the Company’s directors (the "Lender"). The Credit Agreement was amended on November 11, 2022. The Company can borrow up to $6,000,000 under the Credit Agreement ("the "Credit Facility").

The Credit Facility is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this loan without notice, penalty, or charge. In consideration of the Lender’s agreement to provide the Credit Facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under the Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the corresponding notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the Lender additional warrants entitling the Lender to purchase a number of shares of the Company's common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the "VWAP"). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP.

Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. On November 11, 2022, an amendment to the Credit Agreement was signed. The amendment updated the payment terms to the following: "Without limiting the foregoing Section 2.3(a), Borrower shall repay the principal amount of all Advances, plus accrued interest thereon, in 24 equal monthly installments commencing on January 31, 2023 and continuing thereafter on the last day of each month (or, if such last day is not a Business Day, on the Business Day immediately preceding such last day. Interest on the unpaid Advances will accrue from the date of each Advance at a rate equal to fifteen percent (15%) per annum. Interest will be calculated on the basis of 365 days in a year." The amendment raised the maximum amount of the Credit Facility to $6,000,000. In addition, the interest which is accrued monthly between July 1, 2022, and December 31, 2022, will be settled into equity. Common Stock will be issued at the end of each month at a rate of $1.08 per share of common stock in the amount of the interest accrued for each month.

On January 31, 2023, the Company entered into Amendment No.1 (the “Amendment”) to the Amended and Restated Credit Facility Agreement and Convertible Notes which amends our existing Amended and Restated Credit Facility Agreement, dated as of November 11, 2022, between the Company and Thomas B. Akin, a director of the Company (the “Existing Credit Agreement” and as amended by the Amendment, the “Credit Agreement”) and any convertible notes issued thereunder. The Amendment amends the Existing Credit Agreement to extend the maturity of the Credit Agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025, and further provides that any accrued interest on unpaid advances under the Credit Agreement is to be paid quarterly in shares of our common stock, at a price per share equal to the volume-weighted average price of our common stock quoted on the OTCQB® Venture Market operated by OTC Markets Group Inc. over the ninety (90) trading days immediately preceding such date. The Amendment provides for corresponding amendments to the form of convertible note to be issued under the Credit Agreement in the future and any outstanding convertible notes issued under the Existing Credit Agreement.

During the three months ended March 31, 2023, a total of $195,171 of interest was accrued and settled to equity payable for the issuance of 180,715 shares of common stock. The company recorded a loss of settlement of interest payable of $10,315. The company issued 154,106 shares from equity payable related to accrued interest settled during the fourth quarter of 2022.

As of March 31, 2023, the Company had drawn a total of $5,173,125 and we have accrued interest of $387,918.

Unsecured Promissory Note Investments

2020

During February 2018, On July 1, 2021, we conducted a private placement of Unsecured Promissoryentered into UP Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $1,080,000 to certain investors, officers$271,875 with Talkot Fund, LP and directors ofinvestor in the Company. Each UP Note bears interest on the unpaid balance at the rate of 15fifteen percent (15%) per annum and the principal and accrued interest isare due and payable no later than December 1, 2020. 31, 2023. We may prepay any of the UP Notes without notice, subject to a 2two percent (2%) pre-payment penalty. The UP Note offer was conducted by our management and there were 0 commissions paid by us in connection with the solicitation.

On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $200,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of 15 percent (15%) per annum. The Company may prepay this Note without notice, subject to a 2 percent (2%) pre-payment penalty.

On November 18, 2020, we issued 2 additional unsecured Notes in the principle aggregate amount of $500,000, which becomes due two years after the date of issuance. These Notes bear interest on the unpaid balance at the rate of 15 percent (15%) per annum. The Company may prepay these Notes without notice, subject to a 2 percent (2%) pre-payment penalty.

On December 31, 2020 $1,200,000 of these Notes and the accrued interest of $192,208 was settled into equity. We recorded a loss on settlement of debt of $668,260 for the year ended December 31, 2020.

2021

On July 1, 2021 we entered into an Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $271,875 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of 15 percent (15%) per annum and the principal and accrued interest is due and payable no later than July 1, 2023. We may prepay any of the Notes without notice, subject to a 2 percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were 0 commissions paid by us in connection with the solicitation. The Company issued to Talkot Fund LP warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement.

Secured Promissory Note Investments

2021

On June 30, 2021, we entered intoJanuary 31, 2023, the Lender agreed to postpone the 24-month repayment period to a Credit Facility Agreement (the “Credit Agreement”) with onelater period commencing on January 31, 2024, and further agreed that interest accrued on the loan between July 1, 2022 and December 01, 2025 is to be settled in shares of the Company’s directors.common stock quarterly.

During the three months ended March 31, 2023, a total of $10,196 of interest was accrued and settled to equity payable for the issuance of 9,441 shares of common stock. The company recorded a loss of settlement of interest payable of $542 . The company issued 9,651 shares from equity payable related to accrued interest settled during the fourth quarter of 2022.

As of March 31,2023, the Company can borrow up to $3,500,000 under this Credit Agreement. On November 19, 2021,had a payment of $200,000 was paid toward the principal balance of $271,875, and accrued interest of $54,351.  

Related Party Warrant Exercise

On March 2, 2023, Thomas Akin exercised his common stock purchase warrant for 749,987 shares at the note. On November 19, 2021, a paymentexercise price of $200,000 was paid toward$1.00 per share, resulting in additional capital of $749,237. As an inducement for the principal balanceholder’s exercise of the note.warrants, we issued the holders 374,994 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in March 2026.  The Company recorded $120,598 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

On February 7, 2022, Talkot Fund LP exercised his common stock purchase warrant for 750,000 shares at the exercise price of $1.00 per share, resulting in additional capital of $749,250. As an inducement for the holder’s exercise of the warrants, we issued the holders 375,000 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in March 31, 2022,2026.  The Company recorded $120,600 of stock-based expense related to warrants issued during the company has drawnwarrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

12. Subsequent Events

On May 8,2023 a total of $3,478,125 including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility. As of December 31, 2021, we have accrued interest of $149,040. The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022 and ending on June 30, 2024. This loan bears interest on unpaid balance at the rate of 15 percent (15%) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase180,715 shares of its common stock at an exercise pricewere issued to Thomas Akin as settlement of $1.67 per share in connection with the issuanceinterest payable.

On May 8,2023 a total of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance9,441 shares were issued to Talkot Fund, LP as settlement of the notes and ending 36 months after issuanceinterest payable. 

14

11. Subsequent Events

On April 30, 2022 our lease on the office located in Halifax, Nova Scotia expired. We did not renew the lease.

21


Item 2. Management’sManagement's Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains “forward-looking statements”forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in connection with the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially and adversely from those expressed or implied by such forward-looking statements Such forward-looking statements include statements about our expectations, beliefs or intentions regarding our potential product offerings, business, financial condition, results of operations, strategies or prospects. You can identify forward-looking statements by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends, or results as of the date they are made and are often identified by the use of words such as “anticipate,anticipate, “believe,believe, “continue,continue, “could,could, “estimate,estimate, “expect,expect, “intend,intend, “may,may, or “will,will, and similar expressions or variations. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those risks disclosed under the caption “Risk Factors”Risk Factors included in our 2020 annual report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on March30, 2021, and in our subsequent filings with the SEC. Furthermore, such forward-looking statements speak only as of the date of this report. We undertake no obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

Overview

Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized data-driven marketing campaigns.

Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to:

Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence.

Measure, predict, and boost guest frequency and spend by channel.

Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion, and media program.

Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions, and Integrated Loyalty programs.

Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence.

Measure, predict, and boost guest frequency and spend by channel.

Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion and media program.

Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions and Integrated Loyalty programs.

Mobivity’s Recurrency, delivered as a Software-as-a-Service (“SaaS”) platform, is used by leading brands including Subway, Sonic Drive-In, Baskin Robbins, Chick-fil-A and Checkers/Rally’s across more than 40,000 retail locations globally.

We’re living in a data-driven economy. In fact, byBy 2003 — when the concept of “big data”“Big Data” became common vernacular in marketing - as muchthe amount of data was being created every two day as had beendays was equal to the amount created in all of the time prior to 2003. Today, Big Data has grown at such a rate that 90% of the world’s data has been created in just the past two years. Unfortunately, despite there being so much data accumulated, only one percent of data is being utilized today by most businesses.

The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems, and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. WhichThis is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks, and Yum Brands.

Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media, and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental revenue from their customers.

22


The Recurrency Platform

Mobivity’s Recurrency™ platform unlocks valuable POS and mobile data to help transform customer transactions into actionable and attributable marketing insights. Our technology provides transactional data, in real-time, that uncovers market-basket information and attributes both online and traditional promotions. Recurrency is comprised of seven components.components, described in detail below.

POS Data Capture

Recurrency captures, normalizes, integrates, and stores transaction data and is compatible with most POS systems used by restaurants and retailers today. The result is a clean useful dataset upon which to predict and influence customers’ buying behavior and deliver basket-level insights.

Analytics Powered by Machine Learning

Recurrency uses Machine Learning (“ML”) to uncover patterns in the buying behaviors of consumers and leverages that data to suggest pricing optimizations, and guide marketing campaigns.

Offers and Promotions

Recurrency provides a digital wallet system for creating and managing dynamic offers and promotions, enabling accurate and complete closed-loop attribution across all channels, media, and marketing efforts. Retailers can deploy one-time, limited-use, and multi-use promotions across all online and offline marketing channels that are scannable at the POS or redeemable online, enabling fraud-free, controllable promotion delivery and attribution at scale. Marketing teams can use the comprehensive attribution analysis and insights to optimize media mix and spend for maximum Return on Marketing Spend (“ROMS”).

Predictive Offers

Recurrency leverages the normalized data captured at the POS and applies Artificial Intelligence (“AI”) to build profiles of both known and anonymous customers, analyzes pre and post-redemption behavior, and then predicts offers that will drive the highest increases in customer spend and frequency at the lowest discount possible. The result is optimized, personalized promotions that produce the highest ROMS possible.

Personalized Receipt Promotions

Recurrency unlocks the power of transactional data to create relevant and timely customer messages printed on the receipts already being generated at the POS. Both clients and agencies are using Recurrency to drive better results and make decisions around offers, promotions, and customer engagement through the medium of the printed receipt. Software integrated with leading POS systems, such as Oracle or MICROS, or installed directly onto receipt printer platforms, such as Epson’s OmniLink product, dynamically controls what is printed on receipts including images, coupons, announcements, or other calls-to-action, such as invitations to participate in a survey. Recurrency offers a Web-based interface where users can design receipt content and implement business rules to dictate what receipt content is printed in particular situations. All receipt content is also transmitted to cloud-based Recurrency for storage and analysis.

Customized Mobile Messaging

Recurrency transforms standard short message service (“SMS”), multimedia messaging service (“MMS”), and rich communication services (“RCS”) into a data-driven marketing medium. Recurrency tracks and measures offer effectiveness at a more granular level than other solutions, allowing clients to create smarter offers and drive higher redemption rates. Our proprietary platform connects to all wireless carriers so that any consumer, on any wireless service (for example, Verizon), can join our customer’s SMS/MMS mobile marketing campaign. Our customers use Recurrency’s self-service interface to build, segment, target and optimize mobile messaging campaigns to drive increased guest frequency and spend. Recurrency is an industry leader in RCS messaging and has an industry leadingindustry-leading broadcast reach.

Belly Loyalty

Mobivity’s Belly Loyalty solution drives increased customer engagement and frequency with a customer-facing digital rewards platform via an app and digital pad. Using Belly, customers can customize rewards and leverage pre-built email campaigns and triggers to encourage greater frequency as well as to identify and reactivate lapsed customers.

23


Company Strategy

Our objective is to build an industry-leading Software-as-a-Service (“SaaS”)SaaS product that connects consumers to merchants and brands. The key elements toof our strategy are:

Exploit the competitive advantages and operating leverage of our technology platform. The core of our business is our proprietary POS Data Capture technology. Several years of development went into designing POS Data Capture such that the process of intercepting POS data and performing actions, such as controlling the receipt printer with receipt is scalable, portable to a wide variety of POS platforms, and does not impact performance factors including the print speed of a typical receipt printer. Furthermore, we believe the transmission of POS data to Mobivity’s cloud-based data stores presents a very competitive and innovative method of enabling POS data access. Additionally, we believe that our Recurrency platform is more advanced than technologies offered by our competitors and provides us with a significant competitive advantage. With more than ten years of development, we believe that our platform operates SMS/MMS text messaging transactions at a “least cost” relative to competitors while also being capable of supporting the SMS/MMS text messaging transactional volume necessary to serve our goal of several thousand end users. Leveraging our Recurrency platform allows for full attribution of SMS/MMS offers, which we believe is a unique combination of both SMS/MMS text messaging and POS data.

Evolve our sales and customer support infrastructure to uniquely serve very large customer implementations such as franchise-based brands that operate a large number of locations. Over the past few years, we have focused our efforts on the development of our technology and solutions with the goal of selling and supporting small and medium-sized businesses. Going forward, we intend to significantly increase our investments in sales and customer support resources tailored to selling to customers that operate franchise brands. Today we support more than 30,000 merchant locations globally.

Acquire complementary businesses and technologies. We will continue to search and identify unique opportunities which we believe will enhance our product features and functionality, revenue goals, and technology. We intend to target companies with some or all of the following characteristics: (1) an established revenue base; (2) strong pipeline and growth prospects; (3) break-even or positive cash flow; (4) opportunities for substantial expense reductions through integration into our platform; (5) strong sales teams; and (6) technology and services that further build out and differentiate our platform. Our acquisitions have historically been consummated through the issuance of a combination of our common stock and cash.

Build our intellectual property portfolio. We currently have nine issued patents that we believe have significant potential applications in the technology industry. We plan to continue our investment in building a strong intellectual property portfolio.

Exploit the competitive advantages and operating leverage of our technology platform. The core of our business is our proprietary POS Data Capture technology. Several years of development went into designing POS Data Capture such that the process of intercepting POS data and performing actions, such as controlling the receipt printer with receipt is scalable, portable to a wide variety of POS platforms, and does not impact performance factors including the print speed of a typical receipt printer. Furthermore, we believe the transmission of POS data to Mobivity’s cloud-based data stores presents a very competitive and innovative method of enabling POS data access. Additionally, we believe that our Recurrency platform is more advanced than technologies offered by our competitors and provides us with a significant competitive advantage. With more than ten years of development, we believe that our platform operates SMS/MMS text messaging transactions at a “least cost” relative to competitors while also being capable of supporting SMS/MMS text messaging transactional volume necessary to support our goal of several thousand end users. Leveraging our Recurrency platform allows for full attribution of SMS/MMS offers, which we believe is a unique combination of both SMS/MMS text messaging and POS data.

Evolve our sales and customer support infrastructure to uniquely serve very large customer implementations such as franchise-based brands who operate a large number of locations. Over the past few years we have focused our efforts on the development of our technology and solutions with the goal of selling and supporting small and medium-sized businesses. Going forward, we intend to increase significantly our investments in sales and customer support resources tailored to selling to customers that operate franchise brands. Today we support more than 30,000 merchant locations globally.

Acquire complementary businesses and technologies. We will continue to search and identify unique opportunities which we believe will enhance our product features and functionality, revenue goals, and technology. We intend to target companies with some or all of the following characteristics: (1) an established revenue base; (2) strong pipeline and growth prospects; (3) break-even or positive cash flow; (4) opportunities for substantial expense reductions through integration into our platform; (5) strong sales teams; and (6) technology and services that further build out and differentiate our platform. Our acquisitions have historically been consummated through the issuance of a combination of our common stock and cash.

Build our intellectual property portfolio. We currently have nine issued patents that we believe have significant potential application in the technology industry. We plan to continue our investment in building a strong intellectual property portfolio.

While these are the key elements of our current strategy, there can be no guarantees that our strategy will not change or that our strategy will be successful.

Recent Events

Unsecured Promissory Note Investments in 20212023Warrants Exercise

During the yearquarter ended March 30, 2023, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders 1,793,745 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in February 2025. 

2023Related Party Notes Payable

On January 31, 2023, the Company entered into Amendment No. 1 (the “Amendment”) to the Amended and Restated Credit Facility Agreement and Convertible Notes which amends our existing Amended and Restated Credit Facility Agreement, dated as of November 11, 2022, between the Company and Thomas B. Akin, a director of the Company (the “Existing Credit Agreement” and as amended by the Amendment, the “Credit Agreement”) and any convertible notes issued thereunder. The Amendment amends the Existing Credit Agreement to extend the maturity of the Credit Agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025, and further provides that any accrued interest on unpaid advances under the Credit Agreement is to be paid quarterly in shares of our common stock, at a price per share equal to the volume-weighted average price of our common stock quoted on the OTCQB® Venture Market operated by OTC Markets Group Inc. over the ninety (90) trading days immediately preceding such date. The Amendment provides for corresponding amendments to the form of convertible note to be issued under the Credit Agreement in the future and any outstanding convertible notes issued under the Existing Credit Agreement.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, a copy of which was filed with the SEC on the Company's Current Report on Form 8-Kdated January 31, 2021, we2023, and is attached as Exhibit 10.1 to such Current Report on Form 8-K and incorporated herein by reference.

2023Shares Issued

On January 31, 2023 a total of 545,012 shares were issued to John Harris, a former director. The shares were issued based on the total Restricted Stock Units earned by Mr. Harris as director compensation. 

On March 27, 2023 a total of 154,106 shares of common stock were issued to Thomas Akin as settlement of interest payable.

On March 27, 2023 a total of 9,651 shares were issued to Talkot Capital LLC, unsecured Notes in the principal aggregate amountFund LP as settlement of $ 271,875, which are due and payable two years after issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay the advances and accrued interest, in whole or in part, without notice, penalty or charge. As of December 31, 2021, we have $271,875 as a remaining balance of these 2021 Notes and accrued interest of $23,200.payable. 

Unsecured Promissory Note Investments in 2022

As of March 31, 2022, we have $271,875 as a remaining balance of these 2021 Notes and accrued interest of $38,937

Secured Promissory Note Investments in 2021

During the year ended December 31, 2021, we issued to one of our directors, Secured Notes in the principal aggregate amount of $3, 478,125, including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility, which are due and payable two years after issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay the advances and accrued interest, in whole or in part, without notice, penalty or charge. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. As of December 31, 2021, we have $3,278,125 as a remaining balance of these 2021 Notes and accrued interest of $149,040

Secured Note Investments in 2022

24


During the three months period ending March 31, 2022, the Company issued warrants to purchase an aggregate of 20,339 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $6,201 using the Black-Scholes option valuation model as of March 31, 2022.

As of March 31, 2022, we have a principal balance of $3,278,125, discount of $213,754, and accrued interest of $266,427 outstanding under the said Credit Agreement.

Office Relocation

We entered into a six-year office lease starting in February of 2021 for 8,898 square feet of office space located at 3133 W. Frye Road, Suite 215, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, will be $25,953 to $28,733. The first twelve months of the lease includes a 50% abatement period.

Intellectual Property

U.S. Patent number 10,949,868 B1 was granted on March 16, 2021. This patent covers the single use of electronic retailer coupons and referral program. The method and system prevents fraud, is specific to geolocation and provides an audit trail of the customer, cashier and marketing platform. A user can also earn a subsequent coupon by referring a friend.

US Patent number 6,788,769 B1 expired in March of 2021. This patent covered a method and system for using telephone numbers as a key to address email and online content without the use of a look-up database. Using this system, a phone number is used to access a website or an email address in exactly the same way it is used to dial a telephone.

Results of Operations

Revenues

Revenues consist primarily of those generated by a suite of products under the Recurrency platform. The Recurrency platform is comprised of POS Data Capture, Analytics, Offers and Promotions, Predictive Offers, Personalized Receipt Promotions, Customized Mobile Messaging, Belly Loyalty, and other revenues.

Revenues for the three months ended March 31, 2022,2023, were $2,029,569$1,881,482 a decrease of $428,021$148,087 or 17%7% compared to the same period in 2021.2022.

This decrease is primarily due to a decrease in revenue of $420,817 quarterly due to restructuring of customer contract related to Smart Receipt services.subscription fees offset by increased gaming developer sales.

Cost of Revenues

Cost of revenues consistconsists primarily of cloud-based software licensing fees, short code maintenance expenses, messaging relatedmessaging-related expenses, and other expenses.

Cost of revenues for the three months ended March 31, 2022,2023, was $1,174,948, an increase$1,066,575, a decrease of $131,153,$108,373, or 13%9%, compared to $1,174,948for the same period in 2021.2022.

This increasedecrease is primarily due to an increasedecrease in customer acquisitions costs. client text club member acquisition costs from 2022.

General and Administrative

General and administrative expenses consist primarily of salaries and personnel relatedpersonnel-related expenses, consulting costs, and other expenses.

General and administrative expenses decreased $82,194increased $336,930 or 6%,28% to $1,207,176$1,544,106, during the three months ended March 31, 2022,2023, compared to $1,289,370$1,207,176 for the same period in 2021.2022. The decreaseincrease in general and administrative expenseexpenses was primarily due to a decrease in subscriptions, share based compensationexpenses related to the the current warrant exercise and legal fees.

Sales and Marketing

Sales and marketing expenses consist primarily of salaries and personnel relatedpersonnel-related expenses, stock-based compensation expense,expenses, consulting costs, and other expenses.

25


Sales and marketing expenses decreased $299,249increased $93,719, or 33%16%, to $597,501$691,220 during the three months ended March 31, 2022,2023, compared to $896,750$597,501 for the same period in 2021.2022. The decreaseincrease is primarily due to reductionsincreased customer service payroll expenses off set by a decrease in payroll expense and share based compensation and recruiting fees.marketing expenses

.

Engineering, Research & DevelopmentDevelopment$238,446

Engineering, research & development costs include salaries, stock-based compensation expenses, travel, consulting costs, and other expenses.

Engineering, research & development expenses decreased $21,727increased $32,152, or 3%5%, to $702,223$734,375 during the three months ended March 31, 2022,2023, compared to $723,950$702,223 for the same period in 2021.2022. This decreaseincrease is primarily due to the a reduction onand increase in payroll and consulting expenses.

Impairment on Intangible Asset

Impairment on intangible assets consists of an intangible asset valued at less than its carrying value. Impairment on intangible assets decreased 100% from $8,286 to $0 for the three months ended March 31, 2021, compared to the same period in 2021.

Depreciation and Amortization

Depreciation and amortization expenseexpenses consist of depreciation on our equipment and amortization of our intangible assets.

Depreciation and amortization expenseexpenses decreased $33,915$60,410 or 21%49%, to $124,312$63,902 during the three months ended March 31, 20222023 compared to $124,312 for the same period in 2021.This2022. This decrease is primarily due to the reduction in amortization of intangibles on software development costs.due to impairment of intangibles at the end of 2022.

Interest Income

Interest income consists of stated interest income on our cash balances. Interest income decreased $5 or 100% to $0, during the three months ended March 31, 2022, compared to the same period in 2021. This decrease in interest income is related to lower earnings on cash positions held throughout the year compared to the previous year.

Interest Expense

Interest expense consists of stated or implied interest expense on our notes payable, amortization of note discounts, and amortization of deferred financing costs.

Interest expense increased $127,311,$78,619 or 392%49%, to $238,446 during the three months ended March 31, 2022,2023, compared to $32,516$159,827 in the same period in 2021.2022. This increase in interest expense is primarily related to an increase in the balance on the line of borrowingscredit taken out in 2021.

Settlement Losses

Settlement losses consist of legal settlement for TCPA settlements.

Settlement losses for the  three months ended March 31, 2023 were $10,000, an increase of $10,000, compared to $0 for the three months ended March 31, 2022. The increase is due to additional TCPA claims.

Loss on Settlement of Debt

Loss on Settlement of debt consists of the expense from the settlement of notes payable when they are settled into shares.

Loss on settlement of debt for the three months ended March 31, 2023 were $10,857, an increase of $10,857, compared to $0 for the three months ended March 31, 2022 . This increase is due to the amendment allowing for the settlement of interest on our outstanding related parties.party notes payable.

Foreign Currency

The Company’s financial results are impacted by volatility in the Canadian/U.S. Dollar exchange rate. The average U.S. Dollar exchange rate for the three months ended March 31, 2022,2023, was $1 Canadian equals $0.79$0.74 U.S. Dollars. This compares to an average rate of $1 Canadian equals $0.79 during the same period of 2021.in 2022. The Company’s functional or measurement currency is the U.S. Dollar. Based on a U.S. Dollar functional currency, the following are the key areas impacted by foreign currency volatility:

The Company sells products primarily in U.S. Dollars; therefore, reported revenues are not highly impacted by foreign currency volatility.

A portion of the Company’s expenses are incurred in Canadian Dollars and therefore fluctuate in U.S. Dollars as the U.S. Dollar varies. A weaker U.S. Dollar results in an increase in translated expenses, and a stronger U.S. Dollar results in a decrease.

Changes in foreign currency rates also impact the translated value of the Company’s working capital that is held in Canadian Dollars. Foreign exchange rate fluctuations result in foreign exchange gains or losses based upon movement in the translated value of Canadian working capital into U.S. Dollars.

The Company sells products primarily in U.S. Dollars; therefore, reported revenues are not highly impacted by foreign currency volatility.

A portion of the Company’s expenses are incurred in Canadian Dollars and therefore fluctuate in U.S. Dollars as the U.S. Dollar varies. A weaker U.S. Dollar results in an increase in translated expenses, and stronger U.S. Dollar results in a decrease.

Changes in foreign currency rates also impact the translated value of the Company’s working capital that is held in Canadian Dollars. Foreign exchange rate fluctuations result in foreign exchange gains or losses based upon movement in the translated value of Canadian working capital into U.S. Dollars.

The change in foreign currency was a gainloss of  $3,319$31,502 and a loss of $474$12,895 for the three months ended March 31, 2023 and 2022, and 2021, respectively.

Liquidity and Capital Resources

As of March 31, 2022,2023, we had current assets of $2,279,358,$3,544,522, including $1,455,147$2,581,597 in cash, and current liabilities of $6,033,142,$6,602,830, resulting in a working capital deficit of $3,753,789.

26$3,058,308.


We believe as of the date of this report, we do not have the working capital on hand, along with our expected cash flow from operations and budget reductions, to sufficiently fund our current level of operations at least through the end of the next twelve months. However, there can be no assurance that we12 months or beyond. We will not require additional capital. If we require additional capital weand will seek to obtain additional working capital through the sale of our securities and, if available, bank lines of credit. However, thereThere can be no assurance we will be able to obtain access to capital as and when needed, and, if so,or that the terms of any available financing may notwill be subject to commercially reasonable terms.reasonable.

17

Cash Flows

  

Three Months Ended

 
  

March 31,

 
  

2023

  

2022

 

Net cash provided by (used in):

        

Operating activities

 $(1,443,464) $(1,813,845)

Investing activities

  (14,111)   

Financing activities

  3,577,509   2,544,199 

Effect of foreign currency translation on cash flow

  34,923   (10,631)

Net change in cash

 $2,154,857  $719,723 

Three Months

March 31,

 

2022

 

2021

Net cash provided by (used in):

 

Operating activities

$

(1,813,845)

$

(1,901,959)

Investing activities

(126,440)

Financing activities

2,544,199

(221,058)

Effect of foreign currency translation on cash flow

(10,631)

(6,155)

Net change in cash

$

719,723

$

(2,255,612)

Operating Activities

We used cash from operating activities totaling $1,443,464 during the three months ended March 31, 2023 and used cash from operating activities totaling $1,813,845 during the three months ended March 31, 2022 and used cash from operating activities totaling $1,901,959 during the three months ended March 31, 2021. The increase in cash used in operations was primarily due to an increase in net loss of $1,551,051.2022. 

Investing Activities

Investing activities during the three months ended March 31, 2022,2023, consisted of $0$14,111 of equipment purchases andcompared to $0 of capitalized software development costs.in the three months ended March 31, 2022.

Financing Activities

Financing activities during the three months ended March 31, 2023, consisted of proceeds of $3,587,487 from a warrant conversion to common stock and $9,978 in payment on notes payable. Financing activities for the three months ended March 31, 2022 consisted of $ 2,550,553 additional paid in capitalproceeds of $2,550,553 from a warrant conversion to common stock and $6,354 in paymentpayments on notes payable,payable.

Critical Accounting Policies and Estimates

Refer to Note 2, “Summary of Significant Accounting Polices,Policies,” in the accompanying notes to the condensed consolidated financial statements for a discussion of recent accounting pronouncements.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

We are a smaller reporting company as defined by sectionItem 10(f)(1) of Regulation S-K. As such, we are not required to provide the information set forth in this item.

27


Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this report. Disclosure"Disclosure controls and procedures,” as defined in Exchange Act Rule 13a-15(e),  are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, , including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that as of March 31, 20222023 our disclosure controls and procedures were not effective.

As a small company with limited resources that are mainly focused on the development and sales of software products and services, the Company does not employ a sufficient number of staff in its finance department to possess an optimal segregation of duties or to provide optimal levels of oversight. This has resulted in certain audit adjustments and management believes that there may be a possibility for a material misstatement to occur in future periods while it employs the current number of personnel in its finance department.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, that occurred during the three months ended March 31, 20222023 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.


28

18

PART II OTHER INFORMATION

Item 1. Legal Proceedings.

As of the date of this report, the company has one pending legal proceeding related to TCPA (Telephone Consumer Protection Act) Violation. This is a putative class action complaint alleging that Defendant initiated telephone solicitations through text messages in violation of the Florida Telephone Solicitation Act, Fla. Stat. §501.059 (“FTSA”). The defense of the matter was tendered to the Company by its client, Sonic Industries, Inc., and our firm is managing the defense of the matter. The Company intends to seek an individual settlement of the matter, and if one cannot be reached, the Company intends to vigorously defend the matter. The discovery process has not begun so it is not possible at this time to calculate an accurate assessment of the Company’s exposure. No settlement loss has been accrued as it is too early in the proceedings estimate what it if any settlement loss will occur.

During the three months ended March 31, 2023 the Company has settled three TCPA claims for a total settlement loss of $10,000.

Item 1A. Risk Factors.

We are a smaller reporting company, as defined by Item 10(f)(1) of Regulation S-K. As such, we are not required to provide the information set forth in this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the quarter ended March 31, 2023, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders' 1,793,745 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in  February 2025. 

For the foregoing warrants, the exercise price of the warrant and the number of the shares issuable upon exercise of the warrant are subject to customary adjustments prior to exercise upon the occurrence of certain events affecting all outstanding shares of common stock.

The foregoing securities were issued in reliance on an exemption from registration set forth in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) to a limited number of persons who were “accredited investors,” as defined in Rule 501 of Regulation D of the Securities Act, without the use of any general solicitations or advertising to market or otherwise offer the securities for sale. None of the shares, warrants or shares of common stock issued upon exercise of the warrants have been registered under the Securities Act or applicable state securities laws and none may be offered or sold in the United States absent registration under the Securities Act, or an exemption from such registration requirements. Neither this quarterly report on Form 10-Q nor any exhibit attached hereto shall constitute an offer to sell or the solicitation of an offer to buy any securities.

Item 3. Defaults upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information
 

The information set forth below is included herein for purposes of providing the disclosure required under “Item 1.01 Entry Into a Material Definitive Agreement; Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. ” of Form 8-K.

None

On November 13, 2022, the Company entered into an amended and restated credit facility agreement with Thomas B. Akin, a director of the Company (the “A&R Credit Agreement”) and a corresponding convertible note in the amount of $4,466,043 (the “Convertible Note”). The A&R Credit Agreement amends and restates the current Credit Agreement and allows for the Company to borrow up to $6 million in advances. The Convertible Note accrues interest monthly at 15% per annum. Principal and accrued interest payments are due in 24 monthly installments under the Convertible Note beginning on January 31, 2023 and continuing on the last day of each of the next 23 months thereafter. The Convertible Note and all accrued interest thereon are convertible into shares of our common stock, from time to time, at the option of the holder thereof, at a conversion price per share equal to 85% of the volume-weighted average price of our common stock quoted on the OTCQB ® Venture Market operated by OTC Markets Group Inc. over the thirty (30) trading days immediately preceding such date (the “Conversion Price”). The Convertible Note and all accrued interest thereon will be automatically converted into common stock at the Conversion Price on the dated that is five business days prior to the date on which the Company becomes listed on a national securities exchange if all listing requirements have been satisfied by the Company (other than the Company satisfying any stockholders’ equity requirement to be listed on such national exchange).

In addition, in connection with the execution of the A&R Credit Agreement and the Convertible Note, the Company issued Mr. Akin 140,185 shares of common stock on November 14, 2022.

The foregoing description of the A&R Credit Agreement and Convertible Note does not purport to be complete and is qualified in its entirety by reference to the A&R Credit Agreement and Convertible Note, which fill be filed separately.

Item 6. Exhibits

Exhibit No.

Description

Exhibit10.12

Amended and Restated Credit Facility Agreement, dated as of November 11, 2022, between Mobivity Holdings Corp. and Thomas B. Akin *
10.13Convertible Note, dated as of November 15, 2022 *
10.14Amendment No.

1 to Amended and Restated Credit Facility Agreement and Convertible Notes, dated as of January 31, 2023, between Mobivity Holdings Corp. and Thomas B. Akin *
10.15

Description

Form of Exercise Notice for Offer to Amend and Exercise completed March 16, 2023 *
10.16Form of New Warrant issued March 16, 2023 *

31.1

Certification by Chief Executive Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002 *

31.2

Certification by Chief Financial Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002 *

32.1

Certification Pursuant to 18 U.S.C. Section 1350 *

101.INS

Inline XBRL Instance Document *

101.SCH

Inline XBRL Taxonomy Schema Document

101.CAL

Inline XBRL Taxonomy Calculation Linkbase Document *

101.DEF

Inline XBRL Taxonomy Definition Linkbase Document *

101.LAB

Inline XBRL Taxonomy Label Linkbase Document*

101.PRE

Inline XBRL Taxonomy Presentation Linkbase Document *

104Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

* Filed electronically herewith


(1)                         Incorporated by reference to the Registration Statement on Form S-1 filed with the SEC on October 20, 2008, File No. 333-154455

(2)                         Incorporated by reference to the Company’s Current Report on Form 8-K filed December 2, 2011

29

19

SIGNATURESSIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized

Mobivity Holdings Corp.

Mobivity Holdings Corp.

Date: May 15, 2023

By:

Date: May 16, 2022

By:

/s/ Dennis Becker

Dennis Becker

Chairman and Chief Executive Officer

(Principal Executive Officer)

Date: May 16, 202215, 2023

By:

/s/ Lisa Brennan

Lisa Brennan

Chief Financial Officer

(Principal Accounting Officer)

20

30